2018
DOI: 10.4236/crcm.2018.75030
|View full text |Cite
|
Sign up to set email alerts
|

Bisphosphonates Zoledronate and Alendronate for the Management of Postmenopausal Osteoporosis

Abstract: Bisphosphonates are among the most frequently used antiresorptive drugs for the management of postmenopausal osteoporosis. We review here two of the commonly used bisphosphonates zoledronate and alendronate.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
references
References 100 publications
(92 reference statements)
0
0
0
Order By: Relevance